Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.
Acute Disseminated Encephalomyelitis After Influenza Vaccination: A Case Report.
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders.
Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.
Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
The Sphingosine-1-phosphate Analogue, FTY -720, Promotes the Proliferation of Embryonic Neural Stem Cells, Enhances Hippocampal Neurogenesis and Learning and Memory Abilities in Adult Mice.
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
[Clinical and demographic characteristics of patients with multiple sclerosis].
Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation.
Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Diseases More Effectively.
A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon α-2a in a patient with chronic hepatitis B virus infection.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Combined Central and Peripheral Demyelination.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply.
Neuromyelitis optica and pregnancy.
Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
Pages
« first
‹ previous
…
840
841
842
843
844
845
846
847
848
…
next ›
last »